Results 231 to 240 of about 93,945 (299)

Neoadjuvant versus adjuvant chemoradiotherapy for resectable cT3-4a esophageal squamous cell carcinoma: A matched cohort analysis. [PDF]

Precis Radiat Oncol
Lin M, Yu Y, Hu Y, Zheng R, Li J, Yao Q.
europepmc   +1 more source

Oral Health Screening Prior to Oncological Treatment—The Helsinki Protocol

Oral Diseases, EarlyView.
ABSTRACT Objectives Oncological treatments can have adverse effects on oral health and cause long‐term complications such as osteonecrosis. This retrospective study investigated the oral health of head and neck cancer patients before radiotherapy and patients with multiple myeloma, breast, prostate, lung, and kidney cancers before antiresorptive ...
Jemina Järvinen, Johanna Uittamo, Hanna Välimaa, Tero Puolakkainen, Aleksi Haapanen   +4 more
wiley   +1 more source

Efficacy of HALP combined with T2-weighted MRI radiomics in predicting pathological complete response and overall survival in rectal cancer after neoadjuvant chemoradiotherapy: A retrospective single-center study in China. [PDF]

Medicine (Baltimore)
Wan X, Zhu C, Mei D, Liang L, Zhang S, Ge X, Sun X, Li Z, Di X, Xue N, Chen X.   +10 more
europepmc   +1 more source

Clinical Relevance of Lymphovascular and Perineural Invasion in Oral Squamous Cell Carcinoma: Emphasis on Pathological N1 Cases

Oral Diseases, EarlyView.
ABSTRACT Objective This study aimed to investigate the clinical relevance of lymphovascular invasion (LVI) and perineural invasion (PNI) in oral squamous cell carcinoma (OSCC). Methods We conducted a retrospective study of 181 OSCC patients, analyzing clinical outcomes in terms of disease‐specific survival (DSS) and disease‐free survival (DFS ...
Juan Carlos de Vicente, Álvaro Fernández del Valle, Tania Rodríguez Santamarta, Ignacio Peña, Lucas Villalaín Álvarez, Sergi Herrera i Nogués, Ana Martínez‐Carrillo, Miriam Rubiera‐Valdés, Paloma Lequerica‐Fernández   +8 more
wiley   +1 more source

Analysis of Histopathologic Parameters and Patterns of Invasion in Oral Squamous Cell Carcinoma and Their Correlation With Patient Survival

Oral Diseases, EarlyView.
ABSTRACT Introduction Oral squamous cell carcinoma is the most prevalent malignant neoplasm in the head and neck region, and its prognosis is influenced by various histopathological and clinical factors. pTNM tumor staging and invasion patterns are fundamental for predicting therapeutic response and patient survival.
Ana Mirian da Silva Cavalcante, Janderson Fernando da Silva, Tayane Oliveira Gonçalves, Fabrício Bitu Sousa, Erick Ibraim Carlos da Costa, Ana Paula Negreiros Nunes Alves, Jennifer Viana Barbosa, Dayrine Silveira de Paula, Paulo Goberlânio de Barros Silva, Thinali Sousa Dantas   +9 more
wiley   +1 more source

Pan-immune-inflammation value predicts 2-year recurrence after chemoradiotherapy in nasopharyngeal carcinoma. [PDF]

Front Med (Lausanne)
Du K, Li Z, Zhang Q, Liu Z.
europepmc   +1 more source

Decoding host–microbial dynamics in peri‐implantitis: Ecosystem‐specific experimental models

Periodontology 2000, EarlyView.
Abstract Background Peri‐implantitis is an inflammatory disease arising within a unique host–microbial–biomaterial ecosystem. Unlike periodontitis, peri‐implant tissues lack a periodontal ligament and epithelial junction integrity and interface with metal oxides on titanium surfaces.
Georgios A. Kotsakis, Davi Araújo, Asaf Wilensky, Juliana Girón Bastidas, Stella Alimperti, Flavia Pirih   +5 more
wiley   +1 more source

Resectability and Neoadjuvant Chemoimmunotherapy in Stage II-III Non-Small Cell Lung Cancer: A European Case-Vignette Survey. [PDF]

Interdiscip Cardiovasc Thorac Surg
Lampridis S, Patel AJ, Josephides E, Doerr F, Zirafa CC, Hazer S, Obeso A, Bouabdallah I, Casiraghi M, Billè A.   +9 more
europepmc   +1 more source

Advocating for Precision Neoadjuvant and Subsequent Adjuvant Therapies in Esophageal Squamous Cell Carcinoma: Evidence From a Real-World Multicenter Study. [PDF]

MedComm (2020)
Wang P, Wei X, Yu Y, Zhao Z, Ge Q, Lian J, Xing W, Li X, Li Y.   +8 more
europepmc   +1 more source

Multidisciplinary mHealth Rehabilitation for Patients With Abdominal Cancer Who Are Receiving Chemoradiotherapy: Randomized Phase II Trial. [PDF]

J Med Internet Res
Yang L, Wang W, Su J, Xiong Y, Wu H, Wang Y, Dai J, Cao D, Peng J, Xia L, Jiang H, Xu H, Wang Q, Chen F, Shu Q, Hao C, Lv K, Shang W, Xu H, Zhang Y, Chen W, Xu X, Shi H, Zhou F.   +23 more
europepmc   +1 more source